Mergers & Acquisitions - Mergers & Acquisitions, Generics


Popular Filters

176 to 190 of 190 results

STADA to buy Spirig generics business for $109 million; posts 9-month loss due to Serbian difficulties


German drugmaker STADA Arzneimittel (SAZ: GR) has reached agreement with Switzerland’s Spirig Pharma…

FinancialGenericsMergers & AcquisitionsPharmaceuticalSpirig PharmaSTADA Arzneimittel

Biostar Pharma sets out targets as it completes buy of Shaanxi Weinan


Chinese drugmaker Biostar Pharmaceuticals (Nasdaq: BSPM) says that it has completed the previously-announced…

Asia-PacificBiostar PharmaGenericsMergers & AcquisitionsShaanxi Weinan

Sun Pharma offers to acquire remainder of Taro shares


Indian drugmaker Sun Pharmaceuticals (SUN: BO) has proposed to acquire the remaining shares of Israel-based…

GenericsMergers & AcquisitionsPharmaceuticalSun Pharmaceutical IndustriesTaro Pharmaceuticals

Acino pays 80 million euros for Cephalon’s Middle East and African business


Switzerland-based generic and branded drugmaker Acino (SIX: ACIN) says it has reached agreement to acquire…

Acino PharmaCephalonGenericsMergers & AcquisitionsPharmaceuticalRest of the WorldTeva Pharmaceutical Industries

US antitrust body OKs Teva's acquisition of Cephalon, but with divestments


Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA) says that the US Federal Trade Commission…

CephalonGenericsLegalMergers & AcquisitionsNorth AmericaPar PharmaceuticalsPharmaceuticalProvigilTeva Pharmaceutical Industries

Akorn in up to $58 million deal to acquire certain assets of India’s Kilitch Drugs and NBZ Pharma


US niche generics maker Akorn (Nasdaq: AKRX) has entered into an agreement to acquire certain assets…

AkornAntibiotics and Infectious diseasesAsia-PacificGenericsKilitch DrugsMergers & AcquisitionsOncologyOphthalmics

Hikma enters Moroccan market via $111 million controlling stake in Promopharm


Jordan-headquartered Hikma Pharmaceuticals (LSE: HIK) says that it has acquired 63.9% of Promopharm (Societe…

GenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceuticalPromopharmRest of the World

Actavis brings generic Zyprexa to further 11 markets; misses out on buying Polfa


Iceland-headquartered generic drugmaker Actavis Group last week started marketing olanzapine tablets,…

ActavisEli LillyEuropeGenericsMarkets & MarketingMergers & AcquisitionsOlanzapinePolfa WarszawaPolpharmaZyprexa

Teva buys out partner Kowa’s interest in Japanese JV for $150 million


Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA), the world’s largest generic drugmaker,…

Asia-PacificGenericsKowa PharmaceuticalsMergers & AcquisitionsTeva Pharmaceutical Industries

Teva ups stake in CureTech to 75% following positive clinical results in lymphoma


Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA) says it is exercising its option to make an…

CureTechGenericsMergers & AcquisitionsOncologyPharmaceuticalResearchTeva Pharmaceutical Industries

Aurobindo sets up JV with Diod to make and market generic drugs in Russia


Indian drugmaker Aurobindo Pharma (ARBN: BO) and OJSC Diod, a Russian manufacturer of ecological health…

Aurobindo PharmaDiodEuropeFinancialGenericsMarkets & MarketingMergers & Acquisitions

DMV-Fonterra to acquire Brahmar Cellulose in India


Germany’s DMV-Fonterra Excipients, a developer, producer and marketer of excipients to the pharmaceutical…

Brahmar CelluloseDMV-Fonterra ExcipientsGenericsMergers & Acquisitions

Medivir’s new subsid BioPhausia AB sells generics business to Bluefish


Huddinge, Sweden-based infectious disease research specialist Medivir (OMX: MVIR) says it recently-acquired…

BioPhausiaBluefish PharmaceuticalsGenericsMedivirMergers & Acquisitions

Par Pharma to acquire niche generics producer Anchen for $410 million


Par Pharmaceutical (NYSE: PRX) has entered into a definitive agreement to acquire fellow USA-based Anchen…

Anchen PharmaceuticalsGenericsMergers & AcquisitionsPar Pharmaceuticals

176 to 190 of 190 results

Company Spotlight



Back to top